©The Author(s) 2016.
World J Gastroenterol. Nov 14, 2016; 22(42): 9257-9278
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9257
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9257
Table 3 Treatment considerations for investigation of gut-derived immune responses
| Treatment Consideration | Nature | Findings |
| Dietary adjustments | Animal protein, saturated fats[90] | Bacteroides, Firmicutes (including Clostridia), and Prevotella favored by different dietary regimens[37,90] |
| High carbohydrate diets[90] | ||
| Low fat high fiber diet[90] | ||
| Probiotic preparations | Bifidobacterium bifidum[253] | Expands Tregs in cell culture[278] |
| Lactobacillus strains[254,263,266] | Prevents diabetes in NOD mice[263] | |
| Lactobacillus rhamnosus[276] | Improves liver tests in rat model[266] | |
| Anaerostipes caccae[277] | Increases tight junction proteins[276] | |
| Consumes lactate and produces butyrate[277] | ||
| Vitamin A and retinoic acid | Retinoic acid supplement[255] | Restores Lactobacilli in lupus model[255] |
| Dietary vitamin A[256] | Regulates cytokines in lupus model[256] | |
| Induces IL-10-producing Tregs[279] | ||
| Antibiotics | Tetracycline, minocycline[257] | Reduces activity in RA[257] |
| Vancomycin, metronidazole[269] | Improves tests and pruritus in PSC[269] | |
| Re-colonization | Bacteroides fragilis[107] | Induces Tregs in colitis model[107,109,110] |
| Fecal transplantation | Clostridia species[109,110] | |
| Intestinal barrier protectors | Gelatin tannate[258-260] | Enhances mucus barrier[258,259] |
| Reduces activity in murine colitis[259] | ||
| Alters composition of microbiota[259] | ||
| Limits inflammatory effects of LPS[260] | ||
| Inhibits IL-8 and TNF-α in LPS cells[260] | ||
| TLR inhibitors | Oligodeoxynucleotides blocking TLR7 signaling[261] | Improves tests and reduces activity in murine model of lupus nephritis[261] |
| Improves autoimmune lung injury[261] | ||
| Molecular interventions | Polysaccharide A[105,262] | Induces IL-10 producing Tregs[105,262] |
| Protects against EAE in mice[105] | ||
| Short chain fatty acids | Acetate, propionate, butyrate[200] | Modulates gut signaling pathways[200] |
| Inhibits histone deacetylases[200,264] | ||
| Regulates gene expression[200] | ||
| Enhances gut integrity[200] |
- Citation: Czaja AJ. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis. World J Gastroenterol 2016; 22(42): 9257-9278
- URL: https://www.wjgnet.com/1007-9327/full/v22/i42/9257.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i42.9257